A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight ...

Researchers have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them, a finding ...

A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...